BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Apoptosis
,
Inflammatory disorder
,
Hypothalamus
,
Biofuel
,
Lipitor
,
rs3825942
,
PTEN
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NHL 1
Summary
General Info
Curated Studies
Most Correlated Studies
Diffuse large B-cell lymphoma cells after 2D or 3D spheroids co-culture with tonsil stromal cells
Burkitt's lymphoma P3HR1 cells with inducible expression of miR-28 precursor
Treatment of human Non-Hodgkins Lymphoma cell lines with agonistic antibodies
Aggressive B-cell lymphoma, Burkitt's lymphoma, and DLBCL from pediatric patients
B cells from non-Hodgkin lymphomas overexpressing transgenic histone deacetylase 9
Explore Curated Studies Results
Literature
Most Relevant Literature
Differential regulation of the heat shock factor 1 and DAF-16 by neuronal nhl-1 in the nematode C. e…
ABCL-422 Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPC…
Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cel…
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Mal…
Rare presentation of ileocolic intussusception secondary to mantle cell lymphoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL…
Phase 1, Dose-Escalation Study of IGN002 in NHL Subjects
Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL
Phase 1/2A Dose Escalation Study in CLL, SLL or NHL
Trial of DA-EPOCH Regimen for NHL With HLH
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ